Chronic Obstructive Pulmonary Disease
Conditions
Interventions
Treatment with Aerobika.
Sponsors
Mineshita Masamichi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subject has post-long acting bronchodilator forced expiratory volume in first second (FEV1) is less than 80% predicted. Subject has declared that he/she has stopped smoking for at least 8 weeks prior to entering the study. Subject has respiratory symptoms 10 and over on the CAT total score, and has the phlegm symptoms 2 and over on the CAT phlegm score. Subject has read, understood, and signed the informed consent form.
Exclusion criteria
Exclusion criteria: The condition that the investigator judges to exclude from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in FEV1 before and after 4-week treatment with Aerobika. | — |
Secondary
| Measure | Time frame |
|---|---|
| Following parameters will be assessed for before and at 4-week treatment with Aerobika. 1. VC, FVC, V50, and V25 2. IOS (R5, R5ins, R5exp, R20, X5, X5ins, X5exp, Fres, Ax) 3. 6 minute-walking test 4. CAT score, mMRC 5. Acute exacerbation | — |
Contacts
Public ContactMasamichi Mineshita
St. Marianna University School of Medicine
Outcome results
None listed